We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$1.89B
AUM Growth
-$7.83M
(-0.41%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
825
New
253
Increased
155
Reduced
199
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$19.2M |
| 2 |
Beyond Meat
BYND
|
+$18.9M |
| 3 |
Ulta Beauty
ULTA
|
+$15.6M |
| 4 |
Motorola Solutions
MSI
|
+$15.4M |
| 5 |
NXP Semiconductors
NXPI
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$19.2M |
| 2 |
Dollar General
DG
|
+$19M |
| 3 |
Nike
NKE
|
+$18.4M |
| 4 |
Citigroup
C
|
+$18.3M |
| 5 |
Palo Alto Networks
PANW
|
+$17.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.38% |
| 2 | Consumer Discretionary | 12.99% |
| 3 | Healthcare | 12.8% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Charles River Laboratories
CRL
$11.2B
| $1.61M | 0.09% |
+10,555
| New | +$1.46M |
|
352
Zoom
ZM
$28.2B
| $1.6M | 0.09% |
+23,588
| New | +$1.62M |
|
|
VMW
353
DELISTED
VMware, Inc
VMW
| $1.6M | 0.09% |
+10,570
| New | +$1.66M |
|
|
PTLA
354
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.6M | 0.09% |
+67,141
| New | +$1.85M |
|
355
ScottsMiracle-Gro
SMG
$3.82B
| $1.6M | 0.08% |
15,066
-5,300
| -26% | -$542K |
|
356
PTC Therapeutics
PTCT
$5.64B
| $1.6M | 0.08% |
+33,300
| New | +$1.42M |
|
357
Steven Madden
SHOO
$3.37B
| $1.6M | 0.08% |
+37,184
| New | +$1.5M |
|
|
XLNX
358
DELISTED
Xilinx Inc
XLNX
| $1.6M | 0.08% |
+16,331
| New | +$1.53M |
|
359
Casey's General Stores
CASY
$32.2B
| $1.59M | 0.08% |
10,007
-18,100
| -64% | -$3M |
|
|
AMED
360
DELISTED
Amedisys
AMED
| $1.59M | 0.08% |
+9,500
| New | +$1.41M |
|
361
FirstCash
FCFS
$8.85B
| $1.58M | 0.08% |
+19,600
| New | +$1.65M |
|
362
Arrow Electronics
ARW
$11.1B
| $1.58M | 0.08% |
+18,627
| New | +$1.48M |
|
363
Box
BOX
$4.37B
| $1.56M | 0.08% |
+93,239
| New | +$1.56M |
|
364
Bath & Body Works
BBWI
$4.06B
| $1.56M | 0.08% |
+106,571
| New | +$1.54M |
|
|
BLD
365
DELISTED
TopBuild
BLD
| $1.56M | 0.08% |
15,144
+175
| +1% | +$18.2K |
|
366
Lumen
LUMN
$6.57B
| $1.56M | 0.08% |
+118,118
| New | +$1.58M |
|
367
CONMED
CNMD
$1.39B
| $1.55M | 0.08% |
13,909
+8,409
| +153% | +$896K |
|
368
Valvoline
VVV
$4.9B
| $1.55M | 0.08% |
72,462
-26,600
| -27% | -$587K |
|
|
IBKC
369
DELISTED
IBERIABANK Corp
IBKC
| $1.55M | 0.08% |
+20,691
| New | +$1.54M |
|
370
American Financial Group
AFG
$11.8B
| $1.55M | 0.08% |
14,100
-2,700
| -16% | -$289K |
|
371
Dropbox
DBX
$7.6B
| $1.53M | 0.08% |
85,675
-20,700
| -19% | -$390K |
|
372
Flowserve
FLS
$9.71B
| $1.53M | 0.08% |
30,817
-6,600
| -18% | -$316K |
|
373
West Pharmaceutical
WST
$24B
| $1.53M | 0.08% |
10,200
-4,000
| -28% | -$582K |
|
374
Dolby
DLB
$5.56B
| $1.53M | 0.08% |
+22,179
| New | +$1.47M |
|
375
Travelers Companies
TRV
$78.1B
| $1.51M | 0.08% |
+11,062
| New | +$1.51M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Seven Eight Capital held 825 positions worth $1.89B, down 0.41% from $1.89B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
Seven Eight Capital withdrew a net $104M in Q4 2019, closing 218 positions and reducing 199 holdings. Its most notable exit was UnitedHealth, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Workday worth $19M.
- Seven Eight Capital's largest Q4 2019 buy was Workday: 115,611 shares worth $19M.
- Seven Eight Capital added most to Motorola Solutions in Q4 2019, an estimated $15.4M increase.
- Seven Eight Capital's biggest Q4 2019 reduction was Citigroup, cutting an estimated $18.3M.
- Seven Eight Capital fully exited UnitedHealth in Q4 2019, selling an estimated $19.2M.
- Seven Eight Capital's ten largest holdings make up 9.2% of its $1.89B portfolio in Q4 2019.
- Seven Eight Capital opened 253 new positions and closed 218 in Q4 2019.
- Seven Eight Capital's portfolio value fell 0.41% quarter-over-quarter to $1.89B.
Based on Seven Eight Capital's 13F filing for Q4 2019, filed 13 Feb 2020.